{"id":"https://openalex.org/W2334581933","doi":"https://doi.org/10.1097/wnf.0000000000000073","title":"A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease","display_name":"A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease","alternate_titles":[],"publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W2334581933","doi":"https://doi.org/10.1097/wnf.0000000000000073","mag":"2334581933","pmid":"https://pubmed.ncbi.nlm.nih.gov/25768849"},"language":"en","primary_location":{"id":"doi:10.1097/wnf.0000000000000073","doi":"https://doi.org/10.1097/wnf.0000000000000073","is_oa":true,"landing_page_url":"https://doi.org/10.1097/wnf.0000000000000073","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2334581933"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/wnf.0000000000000073","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103642548","display_name":"Tomoyoshi Kondo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tomoyoshi Kondo","raw_affiliation_strings":["*Rehabilitation Hananoie Hospital, Tochigi; and \u2020Juntendo University School of Medicine, Tokyo, Japan","Rehabilitation Hananoie Hospital, Tochigi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Rehabilitation Hananoie Hospital, Tochigi; and \u2020Juntendo University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901"]},{"raw_affiliation_string":"Rehabilitation Hananoie Hospital, Tochigi","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082083783","display_name":"Yoshikuni Mizuno","orcid":"https://orcid.org/0000-0002-1588-5134","observed_orcids":["https://orcid.org/0000-0002-1588-5134"]},"institutions":[{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshikuni Mizuno","raw_affiliation_strings":["Juntendo University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Juntendo University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I34077901"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103642548"],"corresponding_institution_ids":["https://openalex.org/I34077901"],"apc_list":null,"apc_paid":null,"fwci":9.9069,"has_fulltext":false,"cited_by_count":147,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98988874,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"38","issue":"2","first_page":"41","last_page":"46"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/istradefylline","display_name":"istradefylline","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor-antagonist","display_name":"adenosine A2A receptor antagonists","score":0.9769999980926514},{"id":"https://openalex.org/keywords/wearing-off-phenomenon","display_name":"wearing-off phenomenon","score":0.7310000061988831},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.7990000247955322},{"id":"https://openalex.org/keywords/off-time","display_name":"off time","score":0.7820000052452087},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8199999928474426},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/nasopharyngitis","display_name":"nasopharyngitis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/sustained-efficacy","display_name":"sustained efficacy","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.939629077911377},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6831664443016052},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6126643419265747},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.5537452101707458},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.5114737749099731},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5066105127334595},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.479636013507843},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4669787585735321},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44101250171661377},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4334336221218109},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2997756004333496},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.24307963252067566},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/wnf.0000000000000073","doi":"https://doi.org/10.1097/wnf.0000000000000073","is_oa":true,"landing_page_url":"https://doi.org/10.1097/wnf.0000000000000073","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:25768849","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25768849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1097/wnf.0000000000000073","doi":"https://doi.org/10.1097/wnf.0000000000000073","is_oa":true,"landing_page_url":"https://doi.org/10.1097/wnf.0000000000000073","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1493115321","https://openalex.org/W1755157204","https://openalex.org/W1983802226","https://openalex.org/W1990269363","https://openalex.org/W1993724278","https://openalex.org/W2004644468","https://openalex.org/W2028129201","https://openalex.org/W2028285705","https://openalex.org/W2088277236","https://openalex.org/W2090450195","https://openalex.org/W2109889046","https://openalex.org/W2115639304","https://openalex.org/W2118139795","https://openalex.org/W2146659986","https://openalex.org/W2411361607"],"related_works":["https://openalex.org/W6920922630","https://openalex.org/W2028129201","https://openalex.org/W1493115321","https://openalex.org/W3196356517","https://openalex.org/W2088277236","https://openalex.org/W4307813531","https://openalex.org/W1990269363","https://openalex.org/W2761736404","https://openalex.org/W2115639304","https://openalex.org/W4389447296"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Istradefylline":[1,62],"is":[2],"a":[3,37,53,69,215,226],"selective":[4],"adenosine":[5],"A2A":[6],"receptor":[7],"antagonist.":[8],"We":[9],"evaluated":[10],"the":[11,88,99,102,134,164,175,199],"safety":[12],"and":[13,94,127,150,185,195,213],"efficacy":[14,95],"of":[15,58,72,90,109,174],"istradefylline":[16,59,193,208],"administered":[17,64],"once":[18],"daily":[19,103,135],"for":[20,65],"52":[21,66,155,186],"weeks":[22,67,183],"in":[23,44,60,101,114,133,144,156,163,187,198,218,221],"Parkinson":[24],"disease":[25],"(PD)":[26],"patients":[27,46,111,157,188,224],"experiencing":[28,47],"wearing-off":[29,48],"symptoms":[30],"on":[31],"levodopa":[32],"therapy.":[33],"METHODS:":[34],"This":[35,204],"was":[36,63,85,96,141,210],"phase":[38],"3,":[39],"multicenter,":[40],"open-label,":[41],"long-term":[42],"study":[43,57,177,205],"PD":[45,223],"who":[49,158,189],"had":[50,159,190],"previously":[51,160,191],"completed":[52],"double-blind":[54,166,176,201],"placebo-controlled":[55],"clinical":[56],"Japan.":[61],"at":[68,179],"starting":[70],"dosage":[71,78],"20":[73,194],"mg/d,":[74],"with":[75],"or":[76],"without":[77],"adjustment":[79],"up":[80],"to":[81],"40":[82,196],"mg/d.":[83],"Safety":[84],"assessed":[86,97],"using":[87],"incidence":[89],"treatment-emergent":[91,121],"adverse":[92,122],"events,":[93],"as":[98],"change":[100,132],"off":[104,136,169,219],"time.":[105],"RESULTS:":[106],"A":[107],"total":[108],"308":[110],"were":[112,124],"included":[113],"this":[115],"study.":[116,167,202],"The":[117,130,168],"most":[118],"frequently":[119],"reported":[120],"events":[123],"nasopharyngitis":[125],"(24.4%)":[126],"dyskinesia":[128],"(21.4%).":[129],"mean":[131],"time":[137,170,220],"from":[138,172],"day":[139],"1":[140],"-0.65":[142],"hour":[143,152],"week":[145,154],"2,":[146],"fluctuating":[147],"between":[148,182],"-0.71":[149],"-0.04":[151],"until":[153],"taken":[161,192],"placebo":[162],"preceding":[165,200],"reduction":[171,217],"baseline":[173],"remained":[178],"similar":[180],"levels":[181],"2":[184],"mg/d":[197],"CONCLUSIONS:":[203],"showed":[206],"that":[207],"treatment":[209],"well":[211],"tolerated":[212],"produced":[214],"sustained":[216],"levodopa-treated":[222],"over":[225],"52-week":[227],"period.":[228]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2334581933","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":19},{"year":2017,"cited_by_count":24},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
